130 related articles for article (PubMed ID: 11825324)
1. Insulin glargine: the first clinically useful extended-action insulin analogue.
Ashwell SG; Home PD
Expert Opin Pharmacother; 2001 Nov; 2(11):1891-902. PubMed ID: 11825324
[TBL] [Abstract][Full Text] [Related]
2. Insulin glargine: an updated review of its use in the management of diabetes mellitus.
Dunn CJ; Plosker GL; Keating GM; McKeage K; Scott LJ
Drugs; 2003; 63(16):1743-78. PubMed ID: 12904090
[TBL] [Abstract][Full Text] [Related]
3. New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations.
Roach P
Clin Pharmacokinet; 2008; 47(9):595-610. PubMed ID: 18698880
[TBL] [Abstract][Full Text] [Related]
4. An overview of insulin glargine.
Home PD; Ashwell SG
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S57-63. PubMed ID: 12324987
[TBL] [Abstract][Full Text] [Related]
5. Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus.
Chatterjee S; Tringham JR; Davies MJ
Expert Opin Pharmacother; 2006 Jul; 7(10):1357-71. PubMed ID: 16805721
[TBL] [Abstract][Full Text] [Related]
6. Insulin glargine.
Campbell RK; White JR; Levien T; Baker D
Clin Ther; 2001 Dec; 23(12):1938-57; discussion 1923. PubMed ID: 11813930
[TBL] [Abstract][Full Text] [Related]
7. Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue.
Yki-Järvinen H
Eur J Clin Invest; 2004 Jun; 34(6):410-6. PubMed ID: 15200492
[TBL] [Abstract][Full Text] [Related]
8. Insulin glargine (Lantus).
Owens DR; Griffiths S
Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
[TBL] [Abstract][Full Text] [Related]
9. Insulin glargine and its role in glycaemic management of Type 2 diabetes.
Elrishi MA; Jarvis J; Khunti K; Davies MJ
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1099-110. PubMed ID: 18680444
[TBL] [Abstract][Full Text] [Related]
10. Insulin glargine: a new basal insulin.
Levien TL; Baker DE; White JR; Campbell RK
Ann Pharmacother; 2002 Jun; 36(6):1019-27. PubMed ID: 12022906
[TBL] [Abstract][Full Text] [Related]
11. Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Perry CM
Drugs; 2004; 64(22):2577-95. PubMed ID: 15516157
[TBL] [Abstract][Full Text] [Related]
12. Insulin glargine: the first clinically useful extended-acting insulin in half a century?
Home P
Expert Opin Investig Drugs; 1999 Mar; 8(3):307-14. PubMed ID: 15992080
[TBL] [Abstract][Full Text] [Related]
13. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
14. Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.
Duckworth W; Davis SN
J Diabetes Complications; 2007; 21(3):196-204. PubMed ID: 17493554
[TBL] [Abstract][Full Text] [Related]
15. Basal insulin analogues in the management of diabetes mellitus: What progress have we made?
Owens DR; Matfin G; Monnier L
Diabetes Metab Res Rev; 2014 Feb; 30(2):104-19. PubMed ID: 24026961
[TBL] [Abstract][Full Text] [Related]
16. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
Rosenstock J; Dailey G; Massi-Benedetti M; Fritsche A; Lin Z; Salzman A
Diabetes Care; 2005 Apr; 28(4):950-5. PubMed ID: 15793205
[TBL] [Abstract][Full Text] [Related]
17. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
Riddle MC; Rosenstock J; Gerich J;
Diabetes Care; 2003 Nov; 26(11):3080-6. PubMed ID: 14578243
[TBL] [Abstract][Full Text] [Related]
18. Insulin analogues: have they changed insulin treatment and improved glycaemic control?
Madsbad S
Diabetes Metab Res Rev; 2002; 18 Suppl 1():S21-8. PubMed ID: 11921426
[TBL] [Abstract][Full Text] [Related]
19. Insulin glargine: a new long-acting insulin product.
Reinhart L; Panning CA
Am J Health Syst Pharm; 2002 Apr; 59(7):643-9. PubMed ID: 11944604
[TBL] [Abstract][Full Text] [Related]
20. [Medication of the month. Insulin glargine (Lantus)].
Scheen AJ
Rev Med Liege; 2004 Feb; 59(2):110-4. PubMed ID: 15112902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
